Big Pharma Lashes Out At Generic Competition
Brand-name drug manufacturers, facing potentially billions of dollars in losses when their patent protection on drugs expires, are attempting to protect their market shares by slashing prices to undercut the generic...To view the full article, register now.
Already a subscriber? Click here to view full article